2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Lung Transplant Rejection: new trials by email Literature Review of Lung Transplant Rejection trials Research Report on Lung Transplant Rejection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Test How Effective Belumosudil Tablets Are for Treating Adult Participants With Chronic Lung Allograft Dysfunction Belumosudil, Azithromycin, Placebo - Lung Transplant Rejection | Phase 3 | Recruiting | Sanofi | 180 | 2023-10-10 | 2026-10-28 |
| Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) Liposomal Cyclosporine A, standard of care - Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant | Phase 3 | Completed | Zambon SpA | 62 | 2019-03-26 | 2025-10-27 |
| Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2) Liposomal Cyclosporine A, Standard of Care - Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant | Phase 3 | Completed | Zambon SpA | 169 | 2019-03-26 | 2026-02-10 |
Bronchiolitis Obliterans (2) · Rejection, Psychology (2)
Behavior (2) · Bronchial Diseases (2) · Bronchiolitis (2) · Bronchitis (2) · Lung Diseases (2) · Lung Diseases, Obstructive (2) · Respiratory Tract Diseases (2) · Social Behavior (2)
Standard of Care (2) · Azithromycin (1) · belumosudil (1)
Zambon SpA (2) · Sanofi (1)
Belgium (3) · France (3) · Germany (3) · Israel (3) · Spain (3) · United States (3) · Austria (2) · Denmark (2) · United Kingdom (2) · Australia (1) · Canada (1) · China (1) · Czechia (1) · Finland (1) · Hungary (1)
2018 (2), 2023 (1)